Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.
about
Carbapenems: past, present, and futureSubstrate Specificity within a Family of Outer Membrane Carboxylate ChannelsInvolvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosidesMutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosaCharacterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosaA Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosaNew β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China.Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolatesC-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosaAn orphan chemotaxis sensor regulates virulence and antibiotic tolerance in the human pathogen Pseudomonas aeruginosa.Prevalence of Pseudomonas aeruginosa in post-operative wound infection in a referral hospital in Haryana, India.Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesAntibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosaThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.Evaluation of double-disk potentiation and disk potentiation tests using dipicolinic acid for detection of metallo-β-lactamase-producing pseudomonas spp. and Acinetobacter sppThe cell wall amidase AmiB is essential for Pseudomonas aeruginosa cell division, drug resistance and viability.Tn6001, a transposon-like element containing the blaVIM-3-harboring integron In450.Occurrence of blaNDM-₁ & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India.Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamasesStructure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.AmpC beta-lactamases.Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections.Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam.Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria.Prevalence and Clonal Dissemination of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa in Kermanshah.
P2860
Q24634999-16741728-C28D-45BC-8EFB-10F4E3ED8DEFQ27676856-45B8497E-A473-47C8-B660-625711BC7947Q28492529-5DCC12CC-75E4-4E8D-A16B-7931048BA63EQ28492617-19188AD0-D762-4FA9-A75D-070B52E935FDQ28492704-0B6F5D66-EE4A-4895-B435-B9596F5005CEQ28550146-A7F94E88-E1DB-4423-AD3C-3734C5A48269Q33622976-A0C61A35-A3BD-4DF2-A2C7-A3C2BFEFDAB3Q33855601-34EA60C3-48FD-40F3-868C-0BBDA11DF233Q33978241-4A35C4C8-E7CA-4020-A2A7-E41F3AC18E80Q33981394-BFAB6C62-604B-4D53-A417-5C26EAD9D699Q33982298-9E960DF2-BC7B-43A5-B0C1-F46026AE2E24Q34143962-9BA1E6F5-CDC2-42BB-8E77-467AFBBDB687Q34228382-EC1FEAAB-39E6-4E88-9E15-696F56067379Q34369356-C725CA54-FCA9-4FB1-A8F6-B47680C9E039Q34578678-BB24432C-307F-404C-9D0B-DFF4E3DF933FQ34648729-730D0FCF-C5EA-4A39-814A-6EA08A3436C8Q35007624-3EA3C4E3-8D90-4695-A667-87B69B642C2AQ35116174-49341BF9-9E80-4BC2-B4AC-C218EE23C43AQ35482558-4B5C2026-8249-4B0A-97DA-FFB3CF242FA2Q35867456-059E23F4-F016-4926-BA12-C41CE611874EQ36277075-8C1FF92C-CF00-4877-B4E0-F058B45FF189Q36283107-26761685-1F00-428D-8F71-9BE182CC8347Q36295374-6810489F-529F-4119-BF70-695E70F69265Q36347441-E0AEA25A-E48A-4C7F-AD30-3D28DABC9AFAQ36670323-3714E8BC-B25B-49E7-BC6A-8ED04CCE4F01Q37144824-AAA9CF3F-8E08-4C74-A5E2-71EECBC74BF5Q37317645-30F7FB7B-3CC8-4993-8C50-C6218F25379AQ37366249-AB4CF279-6C49-4B80-8434-21810B398A2FQ37598703-3F8020C9-69E7-4602-B6D4-9E9593C277C5Q38841887-E53C515B-924F-4A32-A066-38244518EA50Q39183212-397B746A-DE2E-428E-8BA5-FC7A80662D11Q39267400-F0E4982D-89B1-4EEA-BF47-5EF5213FD78CQ39499725-76A6F1E4-D45E-4671-BE2A-8ACF9A98CF24Q39515144-77E3F6A0-180F-44FD-9D59-64FBD8B83F4FQ39609514-EDF35630-3592-43FF-A81B-100B835EB1E0Q39658709-D3249D41-03BF-4D6A-9E1E-146A22105912Q39767332-2768EF67-237D-4EA7-8BFF-FC12F65B8609Q40334912-918257DC-FBE7-4809-9D5E-5E2D61C23749Q40913105-8246D526-73ED-4864-80C5-D550DAB0B3BDQ40974242-6459FEC7-F9A4-41A6-9061-7D33806E933F
P2860
Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Carbapenem activities against ...... ns of OprD and efflux systems.
@ast
Carbapenem activities against ...... ns of OprD and efflux systems.
@en
type
label
Carbapenem activities against ...... ns of OprD and efflux systems.
@ast
Carbapenem activities against ...... ns of OprD and efflux systems.
@en
prefLabel
Carbapenem activities against ...... ns of OprD and efflux systems.
@ast
Carbapenem activities against ...... ns of OprD and efflux systems.
@en
P2093
P2860
P356
P1476
Carbapenem activities against ...... ons of OprD and efflux systems
@en
P2093
J C Pechere
M Michea-Hamzehpour
P2860
P304
P356
10.1128/AAC.43.2.424
P407
P577
1999-02-01T00:00:00Z